跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 59,965 条关于
“GLP-1/glucagon”
全部
59,965
临床试验
35,610
药物
7,547
机构
1,441
资讯
15,367
去年
OPKO Health and Entera Bio Collaborate to Develop First Oral GLP-1/Glucagon Dual Agonist for Obesity Treatment
去年
OPKO Health and Entera Bio Advance First-in-Class Oral Dual GLP-1/Glucagon Tablet for Obesity Treatment
去年
D&D Pharmatech Completes Enrollment for Phase 2 MASH Trial of Novel Dual GLP-1/Glucagon Agonist DD01
去年
Innovent to Present Phase 3 Results of Dual GLP-1/Glucagon Receptor Agonist Mazdutide at ADA 2025
2年前
GLP-1 Therapies Emerge as Promising Treatment for MASH, Survodutide and Tirzepatide Show Potential
上个月
Neurocrine Biosciences Launches Phase I Trial of GLP-1/GIP/Glucagon Triple Agonist NBIP-1968 for Obesity
去年
Altimmune's Pemvidutide Obesity Program Gains FDA Agreement on Phase 3 Design
去年
Altimmune Achieves FDA Agreement on Phase 3 Program for Pemvidutide in Obesity Treatment
去年
Altimmune Completes Enrollment in Phase 2b IMPACT Trial of Pemvidutide for MASH
2年前
Next-Generation Obesity Drugs Target Muscle Preservation and Enhanced Efficacy Beyond GLP-1 Mechanisms
第 1 页,共 1537 页
上一页
下一页